• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
.[J].Journal Of Pharmaceutical Research,2015,34(10):617-620[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2721times   Download 3269次 QR Code for this article
Scan with your phone!
小分子抑制剂瑞戈非尼的药理和临床概述
王明森1,2,刘正平1,2,侯良玉3,张菊红1,张建强1
Font:Larger+|Default|Smaller-
(1.山东省药学科学院,山东 济南 250101;2.山东福瑞达医药集团公司,山东省黏膜与皮肤给药技术重点实验室,山东 济南 250101;3.山东天浩工程设计有限公司,山东 济南 250101)
摘要:
关键词:  瑞戈非尼  结肠直肠癌  胃肠道间质瘤
DOI:10.13506/j.cnki.jpr.2015.10.019
基金项目:
()
Abstract:
Key words:  
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.